● Last issue 16h ago
Addex Therapeutics | Funded Work
← Back to explore Addex Therapeutics neurological drug
Addex Therapeutics reported its first-half 2026 results while outlining progress across its neurological drug portfolio, including $2.8 million raised through an at-the-market offering and the return of rights to its GABAB positive allosteric modulator program from Indivior.
Signals Press url: https://news.google.com/rss/articles/CBMiXEFVX3lxTFBadEJlX3plcWNYdVNJYWFmLWE4VVF6TjBOVXcwcnRRel9SZmdUYzE5RzVhSER5Tk40R3cwYm9vVXh6Z1NfWXM3MjFkS3A2ZUk1Rk4yRHc5VHB3YVFr?oc=5 · headline: ADXN Stock Price and Chart — NASDAQ:ADXN · publication: TradingView google_news · 10/1/2026 Press url: https://news.google.com/rss/articles/CBMiWkFVX3lxTE13ellTNmhHT2xSS1p6SUVVZVlyM3NxeUlJQzNmOUpvOXVkNi15azNEcndMcVg3RU02NktROWpzSmdDLVM4TDRyellBT3hZYWhpQmJLejJ1Wk8wZw?oc=5 · headline: Addex Therapeutics (ADXN) Stock Price, News & Analysis · publication: MarketBeat google_news · 10/1/2026 Press url: https://news.google.com/rss/articles/CBMiVkFVX3lxTE9yNjhBYVhCOEFWRjdhWHg4ejZ3UElGYnViWmpPaVpRU3EwbEpENVBjV0FGZmM1NW1vT0pKUVY3dy0yV0djMmh0akRqUTU1aWJWQWtTM1Z3?oc=5 · headline: APE Stock Price and Chart — BX:APE · publication: TradingView google_news · 10/1/2026 Press url: https://news.google.com/rss/articles/CBMiUkFVX3lxTFBDV2JjbF9MVVdlOUNJMG0wRFMwTzZJQXJSaEVEb3RleFJhQ1htd29NdDVuQXBObHRFdnRJQkpEQWI3dzZrQk0tOVpFLUhYMFQ5RWc?oc=5 · headline: Addex Therapeutics Ltd (ADXN) Stock Price, News, Quote & History · publication: Yahoo! Finance Canada google_news · 10/1/2026 Press url: https://news.google.com/rss/articles/CBMiWEFVX3lxTE01c1VydzNWV3hGM2IyZ0RaY3ZBOFA0OFAweFB6MEU5dXFwd3dadS1NbVhlaTFVLU5XdkhGalFDMTRfN0VaOXRHdmpZd3lTaEF3WjZ4d2w2bUM?oc=5 · headline: Addex Therapeutics Ltd (ADXN) Company Profile & Facts · publication: Yahoo Finance google_news · 10/1/2026
Press url: https://news.google.com/rss/articles/CBMi8wFBVV95cUxPWmdrb3lPRmpGRGFoYTNVZzVJVWpjWV9BN1BjSUpEY1BpYUs2cVItY2hkYmI1cGtJOWZjdW5FOWhEYnZqRlVXWUt2d0k4VGRiRHoxeGMyQ2hjZ3lvVmk5ZDhHaC16SlpfTldybmQ4VG1MWm1pNmVHV1ZrQnIzVzhSbXVkVXBKbVo3OFVHTG9CR1RKSTg0X1FVenRldS1rQ0h2TGkwT0VkUXdYVkJLQ091WVhLdjRuTFRtUUFZQ1NWR1BGclRfY2tNbld2ZmViYzBhandMcFYwa1JaQ3QzNF84aWljeFhtVzU2ZEdwUE5vNi1DWWs?oc=5 · headline: Neurosterix launches with $63M to Advance Allosteric Modulator Therapeutics for Neurological Disorders · publication: Business Wire google_news · 10/1/2026
Press url: https://news.google.com/rss/articles/CBMipwJBVV95cUxNallaUktuT29DRUJZdm43ZWM4LUlIcUM5SlZCR0NaeXAzcmpkVGc3QUFJR1FfS29XT1dLM2F3ckE0V1B1U3A3a2xydmZPRlFJd0lGMHYzb0JQRXFqd3RYc04tX05KYTVBZWw2RzlyYWdtdlFPTzFDWXh1MUdGSmcyQ05YNmZNQ0c2RWRGSWNaOG5kdHBHQ19WZFhsV2s3N3liS1V1Q2pZNjQ4SFRVQlMtVVZHY24wcmVRbVBaei1vVThTTW8wR2J4TWJPNmZnNEwyZW0wSVhVRjY3MS1vLXN4YndpUWh6ZG91TTBQbEFwNVNrYzZoMDRZWDd2TUczWDdKSmszbnpQNzZHaWN1bGFfS3ZnNlU2R1QyanlYTFJndVo2MUJ2Wl9z?oc=5 · headline: Addex Presents Positive Results from GABAB PAM Cough · publication: GlobeNewswire google_news · 10/1/2026
Press url: https://news.google.com/rss/articles/CBMinAFBVV95cUxNSXJBamM3RGVOR2RUMXlEM1JkZHlQd3ZYdGRwbmo3MEFsRzNUTHROc2NpVzZDREpCWDBlREp2cXNYU0t2dlFMRnVSR3JmcXpwM1NpemgtRmMwXzh1Y0FKUDVlNnpXb05MNHZlbmNnVGVfSUlldGZuRWl6X2ExeXlaUXBFdVNIcG5qNTU0ZThMRVRXREJyeE1saXI3SHQ?oc=5 · headline: Addex’s Partner Discontinues ADX71149 development in Epilepsy · publication: uk.finance.yahoo.com google_news · 10/1/2026
Press url: https://news.google.com/rss/articles/CBMimAFBVV95cUxOM3NIZ01NZ3otdjVoQmhGR3JNYUFqX2d0VG9JZXVtSVVjQVJXSldieUFkY2dVdW1XZ0JsU2FhWGRwYmtqSjByREN1UU81MGNDbGdwTGtHaUFqaE05ekxFRDNuOWxjYXlvb0J0b3lIeWdPMXpXNmdJMWg2aURydEJkTnIyU0lYcmMxR0xPTERURVVzRXZ1YThGdw?oc=5 · headline: Addex Announces Publication of Preclinical Data Supporting Potential of mGlu7 Negative Allosteric Modulators to Transform Anxiety and Fear-Related Disorder Treatment · publication: uk.finance.yahoo.com google_news · 10/1/2026
Press url: https://news.google.com/rss/articles/CBMihAFBVV95cUxPTDltNzB3NGlrM3NOeERHX2VJZ3Q0YnU2aGdEQ3FfV2I2TC00a2I1d0s0R0UxSk1FYkU1QWFCVW82WEMzWEJZY3EyZGVnMmJIUVlJYjY5RmQ2cVpzZlJrRl9JOHpWSWxEcGZxQk1GYTE1bEdKVS1SUGlUSHZseUlrWk9ZMW8?oc=5 · headline: Addex Reports Third Quarter 2024 Financial Results and Provides Corporate Update · publication: Yahoo Finance google_news · 10/1/2026
Press url: https://news.google.com/rss/articles/CBMiiwFBVV95cUxPajk1OTZZUEkxaEg2T0tHZXEzUzZSU2FSSW5HV3A4Nms0Q3U2a004WHdYbEZkUXBiN2lJbzYxamQ5WU5pQzFTd1dRT05xVEFtbkdPT2tpTVhnRWE1dEU1X0NSVXlFVjc5OGIzZkUzS054NlZSeV9jS2RPNFhHR1g5QTYyMFp0VmhseVQ0?oc=5 · headline: Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update · publication: uk.finance.yahoo.com google_news · 10/1/2026
Press url: https://news.google.com/rss/articles/CBMiqAFBVV95cUxNZkUzS1RqRTZSN0tydW5LbTh6djBCa1lTT29ZenZ0djZYODdOTmhfc2cxVUdjYkNTVTRVX29lY3RXSkZYbDltbkgxaE9rMmwwV29JbDZHNGNyaXRrQmhwN2tBX21URXB5WUFBZGZxYklEd2lOekVDMkNrZ0xBSzNFbTJGS1ZuTzJ4YWtEaGYtY0RRb29Mb3N6ZVFLMFlDV1hiU0NWRm5Qazc?oc=5 · headline: Addex Spin-Out Company Neurosterix on Track to Complete Phase 1 Clinical Study of NTX-253 for Schizophrenia in Q2 2026 · publication: Yahoo Finance google_news · 10/1/2026